Pulsatilla chinensis as a New Cholesterol-Lowering Agent
Author Information
Author(s): Song Wei-fang, Wang Rui-jun, Yao Rui-xin, Jiang Qiu-yan, Feng Juan, Luo Kun, Di Zheng-han, Ma Cheng-mei
Primary Institution: Fenyang College, Shanxi Medical University
Hypothesis
Can Pulsatilla chinensis effectively lower cholesterol levels by upregulating LDLR through ERK signaling?
Conclusion
Pulsatilla chinensis acts as an antihypercholesterolemic agent by upregulating LDLR in an ERK-dependent manner.
Supporting Evidence
- PC reduced serum total cholesterol and LDL cholesterol levels in hypercholesterolemic rats.
- PC upregulated LDLR expression in HepG2 cells and rat livers.
- PC treatment improved liver pathology in hypercholesterolemic rats.
- PC was shown to activate ERK signaling, which is crucial for LDLR upregulation.
Takeaway
Pulsatilla chinensis is a plant that can help lower bad cholesterol in the body, making it good for heart health.
Methodology
The study involved high-throughput screening in HepG2 cells and in vivo evaluation in hypercholesterolemic rats, followed by transcriptome analysis and validation through RT-qPCR and western blot techniques.
Limitations
Pulsatilla chinensis is classified as a toxic TCM, necessitating further studies on its active components for safe administration.
Participant Demographics
Male Sprague–Dawley rats aged 6-8 weeks were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website